Neoplasms
Conditions
Brief summary
Cancer treatments can trigger cutaneous side-effects, as well as nail and hair toxicities. When related to drug treatment, this iatrogeny depends on the type of drug, its dosage and individual susceptibility. Although these dermatological adverse events are rarely serious, they can significantly alter patients' quality of life, and may even necessitate the introduction of curative treatment. The impact of these side effects can be mitigated by the use of dermo-cosmetic products and aesthetic solutions. However, most of this supportive care is not reimbursed by the health insurance system, representing a source of inequalities in access to healthcare for cancer patients.
Detailed description
This study aims at establishing, in a cohort of patients with solid tumors, the state of their knowledges, given information and their financial capacities regarding access to dermo-cosmetics and aesthetic solutions, that are used in the attenuation of cancer treatments' side-effects.
Interventions
OTHERQuestionnaires
25-items questionnaire
Sponsors
Institut de cancérologie Strasbourg Europe
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Age \> 18 years * Patients with solid tumors (eligible localization include: digestive system, Head and Neck, Breast, Brain, Lung Tumors, Urological and Gynecologic cancers) * Patients able to read and understand French * Patients that has expressed their consent and with signed consent form
Exclusion criteria
* Minor or patients placed under guardianship or supervision * Patients unable to read French * Patients placed under judicial protection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Describe patients' knowledges regarding cutaneous side-effects, nail and hair toxicities induced by anticancer drugs | at inclusion | 4 items questionnaires |
| Describe patients' knowledges regarding dermo-cosmetics and aesthetic solutions that can attenuate cutaneous side-effects, nail and hair toxicities induced by anticancer drugs | at inclusion | 10 items questionnaires |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Describe patients' socio-economic profile to assess equity regarding access to dermo-cosmetics and aesthetic solutions | at inclusion | 11 items questionnaires |
| Correlate patients' knowledge level depending on tumoral location | at inclusion | Tumoral location as described in medical chart |
| Correlate patients' knowledge level depending on received treatment | at inclusion | Type of chemotherapy administered on the day of inclusion as described in medical chart |
| Correlate patients' knowledge level depending on treatment phase | at inclusion | Type of treatment phase (i.e. neoadjuvant, adjuvant, 1st or 2nd metastatic line) as described in medical chart |
Countries
France
Contacts
Primary ContactManon VOEGELIN
Backup ContactClaire VIT
Outcome results
None listed